INNOSPEC INC. IOSP
Innospec develops, manufactures, blends, markets and supplies a wide range of specialty chemicals to customers in the Americas, Europe, the Middle East, Africa and Asia-Pacific. Our Performance Chemicals business creates innovative technology-based solutions for the personal care, home care, agrochemical, construction, mining and other industrial markets. Our Fuel Specialties business specializes in manufacturing and supplying fuel additives that improve fuel efficiency, boost engine performance and reduce harmful emissions. Our Oilfield Services business supplies chemicals for drilling, completion, production and drag reducing agents ("DRA") which make oil and gas exploration and production more cost-efficient and environmentally friendly.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.78B | $1.85B | $1.95B | $1.96B | $1.48B | $1.19B | $1.51B | $1.48B | $1.31B | $883.4M |
| Cost of revenue | $1.29B | $1.30B | $1.36B | $1.38B | $1.05B | $850.4M | $1.05B | $1.04B | $903.5M | $551.1M |
| Gross profit | $492.4M | $542.9M | $591.1M | $586.7M | $434.9M | $342.7M | $466.2M | $435.0M | $403.3M | $332.3M |
| R&D | $51.0M | $56.5M | $49.0M | $38.7M | $37.4M | $30.9M | $35.4M | $33.4M | $31.4M | $25.4M |
| SG&A | $285.1M | $305.3M | $380.5M | $360.7M | $267.2M | $237.0M | $280.9M | $261.0M | $244.2M | $216.7M |
| Total operating expenses | $362.9M | $365.0M | $429.5M | $399.4M | $302.8M | $309.0M | $316.3M | $301.5M | $278.3M | $234.1M |
| Operating income | $129.5M | $177.9M | $161.6M | $187.3M | $132.1M | $33.7M | $149.9M | $133.5M | $125.0M | $98.2M |
| Pre-tax income | $138.1M | $41.2M | $174.4M | $184.6M | $134.4M | $39.7M | $150.4M | $131.6M | $128.1M | $103.1M |
| Income tax | $21.5M | $5.6M | $35.3M | $51.6M | $41.3M | $11.0M | $38.2M | $46.6M | $66.3M | $21.8M |
| Net income | $116.6M | $35.6M | $139.1M | $133.0M | $93.1M | $28.7M | $112.2M | $85.0M | $61.8M | $81.3M |
| EPS, basic | 4.69 | 1.43 | 5.60 | 5.37 | 3.78 | 1.17 | 4.58 | 3.48 | 2.56 | 3.39 |
| EPS, diluted | 4.67 | 1.42 | 5.56 | 5.32 | 3.75 | 1.16 | 4.54 | 3.45 | 2.52 | 3.33 |
| Shares, diluted (wtd. avg.) | $25.0M | $25.1M | $25.0M | $25.0M | $24.9M | $24.8M | $24.7M | $24.6M | $24.5M | $24.4M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $292.5M | $289.2M | $203.7M | $147.1M | $141.8M | $105.3M | $75.7M | $123.1M | $90.2M | $101.9M |
| Short-term investments | — | — | — | — | — | — | — | — | — | $0 |
| Receivables | $342.3M | $341.7M | $359.8M | $334.6M | $284.5M | $221.4M | $292.0M | $279.7M | $244.5M | $154.4M |
| Inventory | $329.3M | $301.0M | $300.1M | $373.1M | $277.6M | $220.0M | $244.6M | $248.0M | $209.8M | $173.8M |
| Total current assets | $1.00B | $956.6M | $885.7M | $872.6M | $728.1M | $566.2M | $630.3M | $663.9M | $561.5M | $441.1M |
| Property, plant and equipment | $286.1M | $269.7M | $268.3M | $220.9M | $214.4M | $210.8M | $198.7M | $196.4M | $196.0M | $157.4M |
| Goodwill | $2.0M | $382.5M | $399.3M | $358.8M | $364.3M | $371.2M | $363.0M | $364.9M | $361.8M | $374.8M |
| Other intangibles | $67.7M | $65.4M | $57.3M | $45.0M | $57.5M | $75.3M | $113.5M | $136.3M | $163.3M | $144.4M |
| Total assets | $1.83B | $1.73B | $1.71B | $1.60B | $1.57B | $1.40B | $1.47B | $1.47B | $1.41B | $1.18B |
| Accounts payable | $174.7M | $163.8M | $163.6M | $165.3M | $148.7M | $98.7M | $122.0M | $126.8M | $117.9M | $59.6M |
| Short-term debt | — | — | — | — | — | $0 | $0 | $21.4M | $15.8M | $10.3M |
| Total current liabilities | $360.1M | $371.4M | $371.5M | $405.8M | $336.6M | $252.4M | $303.5M | $296.6M | $261.5M | $183.1M |
| Long-term debt | — | — | — | — | — | $0 | $58.6M | $186.2M | $202.6M | $258.5M |
| Total liabilities | $499.5M | $518.6M | $557.8M | $563.3M | $537.9M | — | — | — | — | — |
| Retained earnings | $1.10B | $1.02B | $1.03B | $924.2M | $822.9M | $758.6M | $755.5M | $668.3M | $605.0M | $561.8M |
| Total equity | $1.33B | $1.21B | $1.15B | $1.04B | $1.03B | $944.9M | $918.9M | $825.5M | $794.3M | $653.8M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $138.3M | $184.5M | $207.3M | $81.7M | $93.2M | $145.9M | $161.6M | $104.9M | $82.7M | $105.5M |
| Depreciation and amortisation | $43.6M | $43.5M | $39.3M | $40.1M | $42.7M | $46.0M | $47.6M | $49.6M | $50.4M | $38.1M |
| Stock-based compensation | $8.1M | $8.5M | $8.0M | $6.7M | $4.4M | $5.8M | $6.6M | $4.9M | $4.1M | $3.3M |
| Capital expenditure | $50.3M | $41.4M | $62.1M | $39.6M | $39.1M | $29.7M | $29.9M | $28.9M | $23.3M | $16.5M |
| Investing cash flow | -$75.1M | -$62.0M | -$111.8M | -$42.1M | -$36.2M | -$29.7M | -$31.0M | -$35.5M | -$29.6M | -$209.1M |
| Financing cash flow | -$63.9M | -$35.3M | -$39.0M | -$33.7M | -$20.0M | -$86.8M | -$177.9M | -$36.2M | -$66.4M | $69.5M |
| Dividends paid | $42.4M | $38.8M | $35.1M | $31.7M | $28.8M | $25.6M | $25.0M | $21.7M | $18.6M | $15.9M |
| Buybacks | $23.9M | $700.0K | $1.1M | $5.9M | $800.0K | $2.1M | $2.4M | $1.4M | $1.1M | $8.4M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-056502.
Others in SIC 2800
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| SOLS | Solstice Advanced Materials Inc. | $10.12B | 42.8x | 3.1% |
| PRM | Perimeter Solutions, Inc. | $5.20B | — | 16.4% |
| NGVT | Ingevity Corp | $2.43B | — | -2.7% |
| CC | Chemours Co | $2.30B | — | 0.4% |
| OLN | OLIN Corp | $1.98B | — | 3.7% |
| HUN | Huntsman CORP | $1.69B | — | -5.8% |
| FMC | FMC CORP | $1.62B | — | -18.3% |
| ECVT | Ecovyst Inc. | $1.12B | — | 20.9% |